Note 4 - Stockholders' Deficit - Summary of Options Outstanding and Exercisable by Expiry Date (Details) - $ / shares |
6 Months Ended | |
|---|---|---|
Dec. 31, 2017 |
Jun. 30, 2017 |
|
| Number of Options, Outstanding (in shares) | 150,000 | 150,000 |
| Number of Options, Exercisable (in shares) | 150,000 | 150,000 |
| Range One [Member] | ||
| Expiry Date | Jan. 13, 2019 | |
| Exercise Price, Outstanding (in dollars per share) | $ 0.25 | |
| Number of Options, Outstanding (in shares) | 50,000 | 50,000 |
| Range Two [Member] | ||
| Expiry Date | Jan. 13, 2020 | |
| Exercise Price, Outstanding (in dollars per share) | $ 0.25 | |
| Number of Options, Outstanding (in shares) | 50,000 | 50,000 |
| Range Three [Member] | ||
| Expiry Date | Jan. 13, 2021 | |
| Exercise Price, Outstanding (in dollars per share) | $ 0.25 | |
| Number of Options, Outstanding (in shares) | 50,000 | 50,000 |
| X | ||||||||||
- Definition Date the equity-based award expires, in CCYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|